Navigation Links
Duane Reade Announces Plans for H1N1 Immunization Program
Date:12/17/2009

NEW YORK, Dec. 17 /PRNewswire/ -- Duane Reade, the largest drug store chain in New York City, today announced plans for its H1N1 immunization program as part of the Company's commitment to meet the health and wellness needs of New Yorkers and to be a destination for their flu related needs.

H1N1 immunization vaccines will be offered at select Duane Reade pharmacies in the near term, pending the release of the H1N1 vaccine by the New York City Department of Health. For the most up-to-date information and exact store locations where New Yorkers can receive the H1N1 vaccination, please visit Duane Reade's website at www.duanereade.com/FluShots.aspx or call the customer service hotline at 1-866-DR-LOYAL (1-866-375-6925). Customers may also sign up to receive mobile alerts that will inform them of specific Duane Reade store locations where the vaccine will be available. Interested parties can simply text "flu" to 63103 and follow the instructions when prompted.

"We are very pleased that we will be able to provide this important public service to New Yorkers," said Frank Scorpiniti, Senior Vice President, Pharmacy Operations. "Duane Reade has long been a health and wellness destination for New Yorkers and we are confident that the recent improvements we have made to our operations better equip us to meet our customers' needs as they face a variety of health concerns, including the H1N1 virus. Moreover, we have developed a strong working relationship with New York City's health officials who recognize Duane Reade as a leading provider of health and wellness services for New Yorkers. This will allow us to procure and administer a sizeable number of vaccines and benefit the community at large."

In December 2008 New York became one of the most recent states to enact laws and regulations permitting pharmacists to administer vaccines. In an effort to adapt quickly and to prepare its organization for the H1N1 immunization program, Duane Reade collaborated with the American Pharmacists Association to certify a large number of its pharmacists to administer the H1N1 vaccine. All of Duane Reade's pharmacists are qualified to consult patients and answer questions about the treatment and prevention of the H1N1 virus and seasonal flu, as well as to discuss influenza warning signs and the proper use of antiviral medications and over-the-counter products to treat influenza or relieve flu symptoms.

In addition to offering the H1N1 immunizations, each of Duane Reade's more than 250 stores locations offer seasonal flu supplies such as alcohol-based hand sanitizers and rubs, thermometers, masks, and other flu-related items. Moreover, Duane Reade's pharmacies are fully stocked with Tamiflu and Relenza. In collaboration with New York City health officials, Duane Reade will offer Tamiflu and Relenza at lower costs to those customers who are uninsured and underinsured.

The cost to receive the H1N1 vaccine is $20. Customers who are New York Medicaid and Medicare beneficiaries can receive influenza immunizations at Duane Reade as a covered benefit. All other customers should speak with their insurance providers to determine if the cost of the vaccine is covered under their individual plans.

About Duane Reade

Founded in 1960, Duane Reade is the largest drug store chain in New York City. In keeping with company's brand vision of New York Living Made Easy, Duane Reade provides New Yorkers with prescriptions, health products and services, beauty products and services, food and convenience items for daily life in the City... everything for "How I Feel", "How I Look", and "What I Need Now". The company operates 250+ stores throughout the metropolitan New York region.



    Media Contact:
    Samantha Cohen
    FD
    (212) 850-5600


SOURCE Duane Reade


'/>"/>
SOURCE Duane Reade
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala
2. Connectyx Announces Distribution Partnership with United States Medical Supply
3. Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 10, 2010
4. Ethicon Announces Definitive Agreement to Acquire Acclarent
5. Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
6. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
7. Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects
8. Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening
9. Volcano Announces Installed Base Growth Milestone
10. West Announces First Quarter 2010 Dividend
11. Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ( ... diversifiée innovante, est ravie d,annoncer les excellents résultats semestriels ... période précédente correspondante. Une présentation complète « Résultats et mise ... consultée ici . Faits marquants ... 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Texas based ... In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. ... company had 800 customers and 2,250 RCEs at the time of acquisition. In ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... Mateo, CA (PRWEB) , ... February 26, 2017 , ... ... Area cities as diverse as Millbrae, Belmont, and Palo Alto, is proud to announce ... Mateo. Many Bay Area consumers look for home care close to home, and by ...
(Date:2/26/2017)... ... 26, 2017 , ... ODH, Inc.™ announced today it will exhibit and ... Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., ... improve Medicaid population health management. , ODH will also have an exhibit booth where ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, ... Go. Core benefits and advantages built into the home office sit stand solution ... and feel. Ability to gain the benefits embedded in the TaskMate Go are ...
Breaking Medicine News(10 mins):